TY - JOUR
T1 - Relationships between glucose and mannose during late gestation in normal pregnancy and pregnancy complicated by diabetes mellitus
T2 - Concurrent concentrations in maternal plasma and amniotic fluid
AU - Akazawa, Shoichi
AU - Metzger, Boyd E.
AU - Freinkel, Norbert
PY - 1986/5
Y1 - 1986/5
N2 - Enzymatic assays were modified to permit sensitive and highly reproducible simultaneous measurements of Dmannose and D-glucose in biological fluids during weeks 34 40 of human pregnancy. Plasma mannose and glucose averaged 9.8 ± 0.4 (±SEM) and 790 ± 16 µg/ml, respectively, after an overnight fast in pregnant women (n = 22) with normal carbohydrate metabolism. Significantly higherplasma mannose levels were found, despite only minor increases in plasma glucose, in pregnant women with relatively well controlled diabetes mellitus after an overnight fast (16.9 ± 0.6 µg/ml mannose; 883 ± 29 µgl ml glucose; n = 31) or 3-4 h after breakfast (15.7 ± 1.2 µg/val mannose; 1159 ± 101 µg/ml glucose; n = 19). Plasma mannose correlated significantly withplasma glucose in the women with diabetes mellitus, particularly after an overnight fast. Samples of amniotic fluid were also obtained from the gravida with diabetes mellitus to provide some index of simultaneous relationships in utero. Amniotic fluid mannose and glucose averaged 5.9 ± 0.4 and 302 ± 24 µg/ml, respectively, after an overnight fast and 6.7 ± 1.3 and 459 ± 84 µg/ml 3-4 h after breakfast. In amniotic fluid, as in plasma, the concurrent levels of mannose and glucose conformed to relatively fixed relationships. Thus, othfetus and mother appear to be exposed to readily demonstrable amounts of mannose during late gestation and the absolute as well as relative abundance of mannose may be increased coincident with faulty maternal glucoregulation. However, since mannose did not exceed 3% of the concurrent concentration of glucose in any instance, it does not seem likely that endogenous levels of circulating mannose can modify glucose utilization appreciably by competing with glucose for phosphorylatio via hexokinase and subsequent intracellular processing.
AB - Enzymatic assays were modified to permit sensitive and highly reproducible simultaneous measurements of Dmannose and D-glucose in biological fluids during weeks 34 40 of human pregnancy. Plasma mannose and glucose averaged 9.8 ± 0.4 (±SEM) and 790 ± 16 µg/ml, respectively, after an overnight fast in pregnant women (n = 22) with normal carbohydrate metabolism. Significantly higherplasma mannose levels were found, despite only minor increases in plasma glucose, in pregnant women with relatively well controlled diabetes mellitus after an overnight fast (16.9 ± 0.6 µg/ml mannose; 883 ± 29 µgl ml glucose; n = 31) or 3-4 h after breakfast (15.7 ± 1.2 µg/val mannose; 1159 ± 101 µg/ml glucose; n = 19). Plasma mannose correlated significantly withplasma glucose in the women with diabetes mellitus, particularly after an overnight fast. Samples of amniotic fluid were also obtained from the gravida with diabetes mellitus to provide some index of simultaneous relationships in utero. Amniotic fluid mannose and glucose averaged 5.9 ± 0.4 and 302 ± 24 µg/ml, respectively, after an overnight fast and 6.7 ± 1.3 and 459 ± 84 µg/ml 3-4 h after breakfast. In amniotic fluid, as in plasma, the concurrent levels of mannose and glucose conformed to relatively fixed relationships. Thus, othfetus and mother appear to be exposed to readily demonstrable amounts of mannose during late gestation and the absolute as well as relative abundance of mannose may be increased coincident with faulty maternal glucoregulation. However, since mannose did not exceed 3% of the concurrent concentration of glucose in any instance, it does not seem likely that endogenous levels of circulating mannose can modify glucose utilization appreciably by competing with glucose for phosphorylatio via hexokinase and subsequent intracellular processing.
UR - http://www.scopus.com/inward/record.url?scp=0022627651&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022627651&partnerID=8YFLogxK
U2 - 10.1210/jcem-62-5-984
DO - 10.1210/jcem-62-5-984
M3 - Article
C2 - 3958133
AN - SCOPUS:0022627651
SN - 0021-972X
VL - 62
SP - 984
EP - 989
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 5
ER -